Enhanced recovery after surgery (ERAS) has been proved to be safe and effective in several surgical fields, including gastric cancer, and has been widely applied in clinical practice, covering preoperative, intraoperative and postoperative applications. However, there are still controversies regarding the implementation of ERAS in specific populations of gastric cancer and some specific implementation strategies. At the same time, the clinical application of ERAS also faces many problems. In the future, more high-quality evidence and professional clinical practice teams will be needed to promote the development of ERAS in the gastric cancer field.